A meta-analysis of randomized controlled trials comparing tacrolimus with intravenous cyclophosphamide in the induction treatment for lupus nephritis

Tohoku Journal of Experimental Medicine

Volumn 227, Issue 4, 2012, Pages 281-288

  Deng, Jin ^a   Huo, Dongmei ^b   Wu, Qiaoyuan ^b   Yang, Zhenhua ^b   Liao, Yunhua ^b  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Cyclophosphamide; Lupus nephritis; Meta analysis; Systematic review; Tacrolimus

Indexed keywords

ALBUMIN; CYCLOPHOSPHAMIDE; PREDNISONE; TACROLIMUS;

ALBUMIN BLOOD LEVEL; ALOPECIA; AMENORRHEA; ARTICLE; CHINESE; CREATININE BLOOD LEVEL; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INFECTION; LEUKOPENIA; LIVER FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; MAINTENANCE DRUG DOSE; MENSTRUAL IRREGULARITY; META ANALYSIS; MORBIDITY; MORTALITY; PROTEIN URINE LEVEL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; SIDE EFFECT; SYSTEMATIC REVIEW;

ADULT; COMPLEMENT C3; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; LUPUS NEPHRITIS; MALE; PROTEINURIA; PUBLICATION BIAS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REMISSION INDUCTION; SERUM ALBUMIN; TACROLIMUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84864441487     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.227.281     Document Type: Article

References (32)

1. Appel, G.B., Contreras, G., Dooley, M.A., Ginzler, E.M., Isenberg, D., Jayne, D., Li, L.S., Mysler, E., Sánchez-Guerrero, J., Solomons, N. & Wofsy, D. (2009) Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. J. Am. Soc. Nephrol., 20, 1103-1112.
2. Austin III, H.A., Klippel, J.H., Balow, J.E., Le Riche, N.G.H., Steinberg, A.D., Plotz, P.H. & Decker, J.L. (1986) Therapy of lupus nephritis. N. Engl. J. Med., 314, 614-619.
3. Bao, H., Zhang, H., Zhang, X., Hu, W., Xie, H., Chen, H., Zeng, C., Liu, Z. & Li, L. (2007) A prospective study of multi-target therapy on refractory lupus nephritis. J. Nephrol. Dialy. Transplant., 16, 5-13 (in Chinese, Abstract in English).
4. Bao, H., Liu, Z.H., Xie, H.L., Hu, W.X., Zhang, H.T. & Li, L.S. (2008) Successful treatment of class V+ IV lupus nephritis with multitarget therapy. J. Am. Soc. Nephrol., 19, 2001-2010.
5. Bao, H., Liu, Z., Hu, W., Zhang, H., Xie, H., Chen, H., Zeng, C. & Li, L. (2009) Successful treatment of both proliferative and membranous lupus nephritis with multi-target therapy. J. Nephrol. Dialy. Transplant., 18, 201-206 (in Chinese, Abstract in English).
6. Boumpas, D., Austin, H.A., Balow, J., Vaughan, E., Yarboro, C., Klippel, J. & Steinberg, A. (1992) Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet, 340, 741-745.
7. Chen, W., Tang, X., Liu, Q., Fu, P., Liu, F., Liao, Y., Yang, Z., Zhang, J., Chen, J., Lou, T., Fu, J., Kong, Y., Liu, Z., Fan, A., Rao, S., Li, Z. & Yu, X. (2011) Short-term outcomes of induction therapy with tacrolimus versus cyclophosphamide for active lupus nephritis: a multicenter randomized clinical trial. Am. J. Kidney Dis., 57, 235-244.
8. Chen, Y.E., Korbet, S.M., Katz, R.S., Schwartz, M.M. & Lewis, E.J. (2008) Value of a complete or partial remission in severe lupus nephritis. Clin. J. Am. Soc. Nephrol., 3, 46-53.
9. Feng, P.H. (2007) Systemic Lupus Erythematosus. Ann. N. Y. Acad. Sci., 1108, 114-120.
10. Fine, D.M. (2005) Pharmacological therapy of lupus nephritis. JAMA, 293, 3053.
11. Gourley, M.F., Austin III, H.A., Scott, D., Yarboro, C.H., Vaughan, E.M., Muir, J., Boumpas, D.T., Klippel, J.H., Balow, J.E. & Steinberg, A.D. (1996) Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. Ann. Intern. Med., 125, 549-557.
12. Higgins, J. & Thompson, S.G. (2002) Quantifying heterogeneity in a meta-analysis. Stat. Med., 21, 1539-1558.
13. Houssiau, F. & Ginzler, E. (2008) Current treatment of lupus nephritis. Lupus, 17, 426-430.
14. Houssiau, F.A., Vasconcelos, C., D'Cruz, D., Sebastiani, G.D., de Ramon Garrido, E., Danieli, M.G., Abramovicz, D., Blockmans, D., Mathieu, A., Direskeneli, H., Galeazzi, M., Gül, A., Levy, Y., Petera, P., Popovic, R. et al. (2004) Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. Arthritis Rheum., 50, 3934-3940.
15. Jadad, A.R., Moore, R.A., Carroll, D., Jenkinson, C., Reynolds, D.J.M., Gavaghan, D.J. & McQuay, H.J. (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin. Trials, 17, 1-12.
16. Kamanamool, N., McEvoy, M., Attia, J., Ingsathit, A., Ngamjanyaporn, P. & Thakkinstian, A. (2010) Efficacy and adverse events of mycophenolate mofetil versus cyclophosphamide for induction therapy of lupus nephritis: systematic review and meta-analysis. Medicine, 89, 227-235.
17. Karim, M., Pisoni, C. & Khamashta, M. (2009) Update on immunotherapy for systemic lupus erythematosus - what's hot and what's not! Rheumatology, 48, 332-341.
18. Kjaergard, L.L., Villumsen, J. & Gluud, C. (2001) Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann. Intern. Med., 135, 982-989.
19. Lee, Y.H., Woo, J.H., Choi, S.J., Ji, J.D. & Song, G.G. (2010) Induction and maintenance therapy for lupus nephritis: a systematic review and meta-analysis. Lupus, 19, 703-710.
20. Lee, Y.H., Lee, H.S., Choi, S.J., Dai, Ji. J. & Song, G.G. (2011) Efficacy and safety of tacrolimus therapy for lupus nephritis: a systematic review of clinical trials. Lupus, 20, 636-640.
21. Li, X., Ren, H., Zhang, Q., Zhang, W., Wu, X., Xu, Y., Shen, P. & Chen, N. (2011) Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis. Nephrol. Dial. Transplant., 27, 1467-1472.
22. Miyasaka, N., Kawai, S. & Hashimoto, H. (2009) Efficacy and safety of tacrolimus for lupus nephritis: a placebo-controlled double-blind multicenter study. Mod. Rheumatol., 19, 606-615.
23. Moher, D., Pham, B., Jones, A., Cook, D.J., Jadad, A.R., Moher, M., Tugwell, P. & Klassen, T.P. (1998) Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet, 352, 609-613.
24. Mok, C.C., Ying, S., Yim, C.W. & Ng, W.L. (2010) Tacrolimus (Tac) versus mycophenolate mofetil (MMF) for the treatment of membranous lupus nephritis: a randomized controlled trial (Conference Abstract). Lupus, 19 SUPPL, 16.
25. Moroni, G., Quaglini, S., Gallelli, B., Banfi, G., Messa, P. & Ponticelli, C. (2007) The long-term outcome of 93 patients with proliferative lupus nephritis. Nephrol. Dial. Transplant., 22, 2531-2539.
26. Petri, M. (2004) Cyclophosphamide: new approaches for systemic lupus erythematosus. Lupus, 13, 366-371.
27. Waldman, M. & Appel, G. (2006) Update on the treatment of lupus nephritis. Kidney Int., 70, 1403-1412.
28. Weening, J.J., D'Agati, V.D., Schwartz, M.M., Seshan, S.V., Alpers, C.E., Appel, G.B., Balow, J.E., Bruijn, J.A., Cook, T., Ferrario, F., Fogo, A.B., Ginzler, E.M., Hebert, L., Hill, G., Hill, P. et al. (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int., 65, 521-530.
29. Xu, A., Lu, J., Liang, Y., Wang, Z., Li, J. & Wan, X. (2007) Prospective study of tacrolimus in induction therapy of lupus nephritis. Zhongshan Yi Ke Da Xue Xue Bao, 28, 683-717 (in Chinese, Abstract in English).
30. Zhang, H., Hu, W., Xie, H., Zeng, C., Chen, H. & Liu, Z. (2006a) Tacrolimus versus intravenous cyclophosphamide in the induction therapy of diffuse proliferative lupus nephritis. J. Nephrol. Dialy. Transplant., 15, 501-507 (in Chinese, Abstract in English).
31. Zhang, H., Hu, W., Xie, H., Zeng, C., Chen, H. & Liu, Z. (2006b) Randomized controlled trail of tacrolimus versus intravenous cyclophosphamide in the induction therapy of class plus lupus nephritis. J. Nephrol. Dialy. Transplant., 15, 508-514 (in Chinese, Abstract in English).
32. Zhou, D. & Wu, X. (2011) Meta-analysis of calcineurin inhibitor in the treatment of lupus nephritis. Zhonghua er ke za zhi., 49, 287-293 (in Chinese, Abstract in English).